With the analysis among 1,259 patents, we discovered top 313 key players by total patent application. Boehringer Ingelheim International GmbH, Intarcia Therapeutics, Inc., Alcon AG are dominant in this area. They take 10.09% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 55
Intarcia Therapeutics, Inc.
California, United States
Patent: 38
California, United States
Patent: 32
New York, United States
Patent: 31
New York, United States
Patent: 24
California, United States
Patent: 22
Emilia-Romagna, Italy
Patent: 17
Vascular BioSciences, Inc.
California, United States
Patent: 16
With the analysis among 163 patents, we discovered top 30 start-ups by total patent application. Intarcia Therapeutics, Inc., NantOmics LLC, Carlsmed, Inc. are active in this area.
Intarcia Therapeutics, Inc.
California, United States
Patent: 38
California, United States
Patent: 32
California, United States
Patent: 14
North Carolina, United States
Patent: 8
New York, United States
Patent: 7
Zavante Therapeutics, Inc.
California, United States
Patent: 7
Deverra Therapeutics, Inc.
Washington, United States
Patent: 7
Illinois, United States
Patent: 6
Oncxerna Therapeutics, Inc.
Massachusetts, United States
Patent: 5
California, United States
Patent: 4
With the analysis among related 506 patents applied in the last 5 years. We discover 174 most active companies in this area. The fast-growing Philips, Regents of the University of California, Carlsmed, Inc. take 8.50% of patent filing during this period.
Regents of the University of California
California, United States
Patent: 14
California, United States
Patent: 14
Intarcia Therapeutics, Inc.
California, United States
Patent: 12
California, United States
Patent: 12
Arcutis Biotherapeutics, Inc.
California, United States
Patent: 10
OncoPlex Diagnostics, Inc.
New York, United States
Patent: 7
Deverra Therapeutics, Inc.
Washington, United States
Patent: 7
With the analysis among related 506 patents in last 5 years, we discover 126 new entrants. Carlsmed, Inc., Arcutis Biotherapeutics, Inc., OncoPlex Diagnostics, Inc. are the most active new entrants in this area.
California, United States
Patent: 14
Arcutis Biotherapeutics, Inc.
California, United States
Patent: 10
OncoPlex Diagnostics, Inc.
New York, United States
Patent: 7
Deverra Therapeutics, Inc.
Washington, United States
Patent: 7
Cambridgeshire, United Kingdom
Patent: 7
Washington, United States
Patent: 7
Illinois, United States
Patent: 6
With the analysis among 398 patents, we discovered top 58 universities and scientific research institutions by total patent application. University of Southern California, University of Washington, The Johns Hopkins University are dominant in this area. They take 17.59% of the total patent filing.
University of Southern California
California, United States
Patent: 33
Washington, United States
Patent: 15
The Johns Hopkins University
University of Connecticut Health Center
Connecticut, United States
Patent: 14
Washington University in St. Louis
Missouri, United States
Patent: 6
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 6
Regents of the University of Colorado
Colorado, United States
Patent: 4
New York, United States
Patent: 3
Virginia, United States
Patent: 3